MITOMYCIN-C IN THE CHEMOTHERAPY OF ADVANCED BREAST-CANCER

被引：0
|
作者：
GAREWAL, HS [1 ]
机构：
[1] VET ADM MED CTR,TUCSON,AZ 85723
来源：
SEMINARS IN ONCOLOGY | 1988年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 79
页数：6
相关论文
共 50 条
  • [41] RESPONSE RATES AND TOXICITY OF MITOMYCIN-C, MITOXANTRONE, AND METHOTREXATE (3M) IN ADVANCED BREAST-CANCER
    PORZSOLT, F
    MEURET, G
    ONKOLOGIE, 1991, 14 (04): : 338 - 340
  • [42] A RANDOMIZED TRIAL OF MITOMYCIN-C (M) VERSUS MITOMYCIN-C PLUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MMPA) IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, G
    FALKSON, CB
    FALKSON, HC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 14 - 17
  • [43] FIXED DOSE SHORT COURSE MITOMYCIN-C WITH VINCRISTINE IN ADVANCED PRE-TREATED BREAST-CANCER
    MILLWARD, MJ
    HENDRICK, A
    CANTWELL, BMJ
    ANNALS OF ONCOLOGY, 1990, 1 (05) : 373 - 374
  • [44] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [45] A PHASE-II STUDY OF COMBINED 5-FLUOROURACIL AND MITOMYCIN-C IN ADVANCED BREAST-CANCER
    MATTSSON, W
    VONEYBEN, F
    HALLSTEN, L
    BJELKENGREN, G
    CANCER, 1982, 49 (02) : 217 - 220
  • [46] MITOMYCIN-C, MITOXANTRONE (MX) AS 2ND LINE THERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER
    BISHOP, JF
    JEAL, PN
    HILLCOAT, BL
    RAGHAVAN, D
    COATES, A
    LEVI, J
    WOODS, R
    BURNS, I
    SNYDER, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (04): : 295 - 295
  • [47] SALVAGE CHEMOTHERAPY WITH MITOXANTRONE AND MITOMYCIN WITH OR WITHOUT METHOTREXATE IN ADVANCED BREAST-CANCER
    ASTONE, A
    CASSANO, A
    FONTANA, T
    NOVIELLO, MR
    POZZO, C
    BARONE, C
    ANTI-CANCER DRUGS, 1992, 3 (05) : 471 - 473
  • [48] MITOMYCIN-C IS AN INACTIVE DRUG IN THE 3RD-LINE TREATMENT OF HORMONE AND CHEMOTHERAPY REFRACTORY BREAST-CANCER
    DEES, A
    VERWEIJ, J
    VANPUTTEN, WLJ
    STOTER, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09): : 1343 - 1347
  • [49] MITOMYCIN-C AND MITOXANTRONE IN ANTHRACYCLINE-PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY
    PERRONE, F
    DEPLACIDO, S
    CARLOMAGNO, C
    GRAVINA, A
    DELAURENTIIS, M
    DELMASTRO, L
    GRIDELLI, C
    PAGLIARULO, C
    BIANCO, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (03): : 218 - 222
  • [50] A PILOT COMBINATION OF DIBROMODUCITOL, ADRIAMYCIN, AND TAMOXIFEN (DAT) VERSUS MITOMYCIN-C AND TAMOXIFEN (MT) FOR ADVANCED BREAST-CANCER
    CHANG, YC
    FALKSON, G
    TORMEY, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 147 - 147
12345